Codexis (CDXS) Debt Ratio (2017 - 2026)
Codexis (CDXS) recorded quarterly Debt Ratio of 0.31 in Q1 2026, up 15.32% quarter-over-quarter from 0.27 in Q4 2025, and up 38.19% on a YoY basis from 0.23 in Q1 2025.
Codexis (CDXS) Debt Ratio (2017 - 2026) Analysis & Trends
Codexis' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.31 for Q1 2026.
- In Q1 2026, Debt Ratio rose 38.19% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (up 38.19% YoY), while the FY2025 annual figure was 0.27, up 39.89% from the prior year.
- Debt Ratio was 0.31 for Q1 2026 at Codexis, up from 0.27 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.32 in Q3 2025 to a low of 0.19 in Q1 2024.
- Historically, Debt Ratio has averaged 0.25 across 3 years, with a median of 0.23 in 2025.
- Biggest YoY gain for Debt Ratio was 65.88% in 2025; the steepest drop was 20.51% in 2025.
- A 3-year view of Debt Ratio shows it stood at 0.19 in 2024, then soared by 39.89% to 0.27 in 2025, then climbed by 15.32% to 0.31 in 2026.
- The last three Debt Ratio figures came in at 0.31 (Q1 2026), 0.27 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.21 |
| Mar 31, 2024 | 0.19 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.01 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | 0.01 |
| Mar 31, 2017 | 0.01 |